NCT03130634View on ClinicalTrials.gov

The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

January 31, 2020

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Silymarin

During six cycles of FOLFIRI chemotherapy, the patients will take silymarin (150mg) three times daily from day 1 to day 7 during one cycle of treatment.

Trial Locations (1)

807

Chung-Ho Memorial Hospital, Kaohsiung Medical University:, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT03130634 - The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment | Biotech Hunter | Biotech Hunter